Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MDCO | Medicines Company | -1.61% | 47.76 | 20.3% | $139.37m | |
| VRX | Valeant Pharmaceuticals International, Inc. | -2.11% | 23.25 | 14.1% | $136.81m | |
| AMRN | Amarin Corporation Plc Sponsored ADR | -0.24% | 16.71 | 1.8% | $106.43m | |
| PRGO | Perrigo Co. Plc | 0.04% | 55.98 | 6.8% | $65.35m | |
| JAZZ | Jazz Pharmaceuticals Plc | -0.03% | 131.41 | 2.3% | $62.65m | |
| GWPH | GW Pharmaceuticals PLC Sponsored ADR | -0.99% | 141.01 | 6.2% | $59.44m | |
| SAGE | SAGE Therapeutics, Inc. | -0.69% | 159.79 | 8.6% | $55.88m | |
| CTLT | Catalent Inc | -1.19% | 51.33 | 2.4% | $42.63m | |
| MNK | Mallinckrodt Plc | -5.01% | 3.13 | 20.9% | $41.91m | |
| ENDP | Endo International Plc | -2.02% | 3.88 | 8.8% | $39.68m | |
| UTHR | United Therapeutics Corporation | 1.09% | 80.69 | 14.3% | $30.77m | |
| PTLA | Portola Pharmaceuticals, Inc. | 0.72% | 30.68 | 6.7% | $30.44m | |
| ICPT | Intercept Pharmaceuticals, Inc. | 1.22% | 68.90 | 16.9% | $29.88m | |
| ICLR | ICON Plc | 0.25% | 149.92 | 4.1% | $28.03m | |
| AERI | Aerie Pharmaceuticals, Inc. | -4.41% | 22.09 | 6.8% | $26.55m |
Company Profile
United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. It markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. The firm also involves in the research and development of new indications and delivery devices for its product, and for the organ transplantation-related technologies. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.